Glycolysis inhibition as a cancer treatment and its role in an anti-tumour immune response

KS Gill, P Fernandes, TR O'Donovan… - … et Biophysica Acta (BBA …, 2016 - Elsevier
Increased glycolysis is the main source of energy supply in cancer cells that use this
metabolic pathway for ATP generation. Altered energy metabolism is a biochemical …

[HTML][HTML] Prognostic factors related with survival in patients with pancreatic adenocarcinoma

A Bilici - World Journal of Gastroenterology: WJG, 2014 - ncbi.nlm.nih.gov
The prognosis in patients with pancreatic cancer is poor and this cancer is the fourth leading
cause of cancer-related death worldwide. Although surgical resection is the only curative …

FOXM1 promotes the warburg effect and pancreatic cancer progression via transactivation of LDHA expression

J Cui, M Shi, D Xie, D Wei, Z Jia, S Zheng, Y Gao… - Clinical Cancer …, 2014 - AACR
Abstract Purpose: The transcription factor Forkhead box protein M1 (FOXM1) plays critical
roles in cancer development and progression. However, the regulatory role and underlying …

Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis

MI Koukourakis, A Giatromanolaki, E Sivridis… - British journal of …, 2003 - nature.com
Abstract Lactate dehydrogenase-5 (LDH-5) catalyses the reversible transformation of
pyruvate to lactate, having a principal position in the anaerobic cellular metabolism …

Lactate dehydrogenase 5 (LDH5) relates to up-regulated hypoxia inducible factor pathway and metastasis in colorectal cancer

MI Koukourakis, A Giatromanolaki… - Clinical & experimental …, 2005 - Springer
Abstract Lactate dehydrogenase 5 (LDH5) is one of the five LDH isoenzymes and,
apparently, the most important for promoting anaerobic glycolysis. LDH5 is transcriptionally …

Lactate dehydrogenase-5 (LDH-5) expression in human gastric cancer: association with hypoxia-inducible factor (HIF-1α) pathway, angiogenic factors production and …

Y Kolev, H Uetake, Y Takagi, K Sugihara - Annals of surgical oncology, 2008 - Springer
Abstract Background Lactate-dehydrogenase-5 (LDH-5) is an important isoenzyme
converting pyruvate to lactate under hypoxic conditions and might play an important role in …

Oxidative stress: a new target for pancreatic cancer prognosis and treatment

J Martinez-Useros, W Li, M Cabeza-Morales… - Journal of clinical …, 2017 - mdpi.com
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal types of tumors, and its
incidence is rising worldwide. Survival can be improved when tumors are detected at an …

Lactate dehydrogenase 5 expression in operable colorectal cancer: strong association with survival and activated vascular endothelial growth factor pathway—a …

MI Koukourakis, A Giatromanolaki, E Sivridis… - Journal of clinical …, 2006 - ascopubs.org
Purpose Lactate dehydrogenase 5 (LDH-5) regulates, under hypoxic conditions, the
anaerobic transformation of pyruvate to lactate for energy acquisition. Several studies have …

[HTML][HTML] Prognostic and predictive factors in pancreatic cancer

E Dell'Aquila, CAM Fulgenzi, A Minelli, F Citarella… - Oncotarget, 2020 - ncbi.nlm.nih.gov
Pancreatic cancer is one of the leading causes of cancer death worldwide. Its high mortality
rate has remained unchanged for years. Radiotherapy and surgery are considered standard …

Functional inhibition of lactate dehydrogenase suppresses pancreatic adenocarcinoma progression

C Cheng, HY Tan, N Wang, L Chen… - Clinical and …, 2021 - Wiley Online Library
Background Pancreatic adenocarcinoma (PAAD) a highly lethal malignancy. The current
use of clinical parameters may not accurately predict the clinical outcome, which further …